Deep Dive on Oncology | pharmaphorum

Deep Dive

Views & Analysis

Enabling healthcare’s digital future

Debiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides to improve patient outcomes

Views & Analysis

Digital health developments: a new investment era for start-...

Healthware Labs’ Kristin Milburn explores how digital health start-ups can harness the huge potential for the sector in a post-COVID world and the paths they need to take to grow their busi

Views & Analysis

Why pharma shouldn’t forget about sites in a post-COVID worl...

The pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we must recalibrate and work with sites to understand the value proposition of t

Views & Analysis

Deep Dive: Oncology 2021

This has probably been the toughest year for oncology researchers in memory.

Views & Analysis

GSK’s John Fleming on rethinking oncology from the ground up

What if we could look at cancer treatment from a completely fresh perspective?

Views & Analysis

Commercialising innovative new medicines

As pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination of evidence generation and communication

Enabling healthcare’s digital future

Digital health developments: a new investment era for start-...

Why pharma shouldn’t forget about sites in a post-COVID worl...

Deep Dive: Oncology 2021

GSK’s John Fleming on rethinking oncology from the ground up

Commercialising innovative new medicines

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

Deep Dive

Editor's Picks